Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 166 across all filing types
Latest filing 2022-12-23 M&A Activity
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
MedCap fullföljer sitt rekommenderade kontanterbjudande till aktieägarna i AdderaCare och förlänger acceptfristen
M&A Activity Classification · 1% confidence The document is a press release dated December 23, 2022, detailing the outcome and extension of a recommended cash offer (Erbjudandet) by MedCap AB for AdderaCare AB. Key phrases include 'MedCap fullföljer sitt rekommenderade kontanterbjudande' (MedCap completes its recommended cash offer) and discussions about acceptance levels (94.57%) and extending the acceptance deadline. This content directly relates to a takeover bid or merger proposal, which aligns with the definition for M&A Activity (TAR). It is not a full Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it concerns a specific corporate transaction (takeover/acquisition). It is also not a Report Publication Announcement (RPA) because it contains substantive details about the transaction's status, not just an announcement that a report is available.
2022-12-23 Swedish
Erbjudandehandling avseende erbjudande till aktieägarna i AdderaCare offentliggjord
M&A Activity Classification · 1% confidence The document is a press release dated December 1, 2022, announcing the publication of the offer document ('Erbjudandehandling') related to a public takeover bid by MedCap AB for AdderaCare AB. This involves a proposal for the acquisition of control over another company, which falls under Merger & Acquisition (M&A) activity. The specific filing category for M&A activity is 'TAR' (Takeover Activity/Merger Proposal). Although it is a press release, its primary function is to announce the formal takeover offer documentation, making TAR more specific than a general RPA or RNS.
2022-12-01 Swedish
MedCap AB (publ) offentliggör ett rekommenderat kontant-erbjudande om 3,60 kronor per aktie till aktieägarna i AdderaCare AB (publ)
M&A Activity Classification · 1% confidence The document is a press release from MedCap AB announcing a recommended cash offer to acquire all shares of AdderaCare AB. Key phrases include "offentliggör ett rekommenderat kontanterbjudande" (announces a recommended cash offer), details about the offer price (3.60 SEK per share), premium calculations, and shareholder acceptance commitments. This clearly indicates an action related to a takeover bid or merger proposal. According to the definitions, this falls under M&A Activity (TAR). Although it is a press release, the content is the core announcement of the transaction itself, not just an announcement that a document will follow (which would be RPA/RNS).
2022-11-17 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for MedCap AB for the period July-September 2022. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance for the third quarter and the first nine months of the year. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-10-28 Swedish
Valberedning i MedCap utsedd
Board/Management Information Classification · 1% confidence The document is a press release dated October 12, 2022, announcing the composition of the Nomination Committee (Valberedning) for the upcoming Annual General Meeting (AGM) in 2023. The text details who appointed the members and outlines the committee's tasks, which include proposing board members, auditors, and remuneration for the AGM. This type of announcement, concerning the preparation for the AGM, specifically the nomination of candidates and related governance structure, aligns best with the 'AGM Information' category, as it is directly related to the proceedings and structure of the Annual General Meeting. While it is an announcement, it is a specific announcement about the AGM structure rather than a general report publication (RPA) or a general regulatory filing (RNS).
2022-10-12 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period April-June 2022 for the company MedCap. It contains comprehensive financial statements, including income statements, balance sheet summaries, cash flow analysis, and management commentary on business performance for the quarter and the first half of the year. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). Q2 2022
2022-07-29 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.